Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-03

Clinical Trial Update: The Serotonin Transporter in Attention Deficit Hyperactivity Disorder

View source ↗

Summary

A clinical trial conducted by the Medical University of Vienna evaluating the serotonin transporter in Attention Deficit Hyperactivity Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Vienna | Conditions: Attention Deficit Hyperactivity Disorder | Status: COMPLETED